Search form
Search
About us
Oxurion at a glance
Our milestones
Our mission
Our team
Partnerships
Careers
Science
Unmet medical need
We focus on non-VEGF pathways
Back of the eye disorders
Back of the eye
Diabetic eye disease
Symptomatic VMA/VMT
Pipeline
THR-149 (PKal Inhibitor)
Science team
Investors
Shareholder Information
Reports & presentations
Analyst Coverage
Conferences & Events
Financial calendar
Corporate governance
Investor relations contact
Archived Events
News & Events
Latest news
Media contact
Contact
Menu
About us
Oxurion at a glance
Our milestones
Our mission
Our team
Partnerships
Careers
Science
Unmet medical need
We focus on non-VEGF pathways
Back of the eye disorders
Back of the eye
Diabetic eye disease
Symptomatic VMA/VMT
Pipeline
THR-149 (PKal Inhibitor)
Science team
Investors
Shareholder Information
Reports & presentations
Analyst Coverage
Conferences & Events
Financial calendar
Corporate governance
Investor relations contact
Archived Events
News & Events
Latest news
Media contact
Contact
Developing next generation treatments to preserve vision for patients with diseases affecting the back of the eye
Front page
Front page of
Oxurion — Advancing Science. Enhancing Vision